Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

EW

Edwards Lifesciences Corp

Dec 13 • 04:00PM ET

73.32

Dollar change -0.65
Percentage change -0.88	%

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT BSX SYK ISRG ZBH TFX COO ALGN

| Held by: VTI VOO SPY IVV VUG VO XLV IHI RSP VOT

Scroll to Statements

Index	S&P 500	P/E	10.58	EPS (ttm)	6.93	Insider Own	1.74%	Shs Outstand	589.80M	Perf Week	2.50%
Market Cap	42.86B	Forward P/E	29.96	EPS next Y	2.45	Insider Trans	-0.74%	Shs Float	579.56M	Perf Month	10.22%
Income	4.16B	PEG	1.51	EPS next Q	0.55	Inst Own	84.52%	Short Float	1.48%	Perf Quarter	5.71%
Sales	5.87B	P/S	7.30	EPS this Y	2.37%	Inst Trans	-2.25%	Short Ratio	1.47	Perf Half Y	-16.00%
Book/sh	16.18	P/B	4.53	EPS next Y	-4.74%	ROA	13.01%	Short Interest	8.58M	Perf Year	-2.53%
Cash/sh	7.61	P/C	9.63	EPS next 5Y	7.00%	ROE	17.93%	52W Range	58.93 - 96.12	Perf YTD	-3.84%
Dividend Est.	-	P/FCF	83.15	EPS past 5Y	15.35%	ROI	40.66%	52W High	-23.72%	Beta	1.13
Dividend TTM	-	Quick Ratio	2.89	Sales past 5Y	10.28%	Gross Margin	77.38%	52W Low	24.42%	ATR (14)	2.02
Dividend Ex-Date	-	Current Ratio	3.46	EPS Y/Y TTM	195.52%	Oper. Margin	27.22%	RSI (14)	59.75	Volatility	2.78% 2.75%
Employees	19800	Debt/Eq	0.07	Sales Y/Y TTM	0.92%	Profit Margin	70.82%	Recom	2.33	Target Price	77.96
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	713.03%	Payout	0.00%	Rel Volume	0.51	Prev Close	73.97
Sales Surprise	-12.31%	EPS Surprise	0.81%	Sales Q/Q	-8.54%	Earnings	Oct 24 AMC	Avg Volume	5.84M	Price	73.32
SMA20	2.63%	SMA50	5.83%	SMA200	-6.76%	Trades		Volume	2,969,659	Change	-0.88%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-11-24	Resumed	Morgan Stanley	Equal-Weight	$70
Sep-18-24	Downgrade	Jefferies	Buy → Hold	$85 → $70
Jul-31-24	Upgrade	Daiwa Securities	Neutral → Outperform
Jul-29-24	Upgrade	Wolfe Research	Underperform → Peer Perform
Jul-25-24	Downgrade	Truist	Buy → Hold	$110 → $82
Jul-25-24	Downgrade	TD Cowen	Buy → Hold	$100 → $70
Jul-25-24	Downgrade	Robert W. Baird	Outperform → Neutral	$102 → $70
Jul-25-24	Downgrade	JP Morgan	Overweight → Neutral	$105 → $72
Jul-25-24	Downgrade	BofA Securities	Buy → Neutral	$105 → $75
May-30-24	Initiated	Goldman	Buy	$107
May-22-24	Upgrade	Citigroup	Neutral → Buy	$98 → $105
May-14-24	Upgrade	Deutsche Bank	Hold → Buy
Mar-07-24	Upgrade	BofA Securities	Neutral → Buy
Feb-02-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$94
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$80 → $77
Dec-11-23	Downgrade	Citigroup	Buy → Neutral
Nov-28-23	Downgrade	Wolfe Research	Peer Perform → Underperform	$57
Sep-26-23	Upgrade	Oppenheimer	Perform → Outperform	$90
Jul-19-23	Initiated	Robert W. Baird	Outperform	$107
May-30-23	Resumed	Morgan Stanley	Overweight	$102

Show Previous Ratings

Dec-12-24 06:50AM	Capstan Medical raises $110M for heart valve with robotic system (MedTech Dive)
Dec-05-24 07:17AM	Edwards expects new TAVR approval in mid-2025 to boost sales (MedTech Dive)
Dec-04-24 07:41PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research) +5.70%
04:41PM	S&P 500 Gains and Losses Today: Salesforce Stock Pops as AI Offering Impresses (Investopedia)
11:40AM	Edwards Lifesciences Outlines Vision For Growth At Investor Conference (Benzinga)
06:17AM	Loading…
06:17AM	Edwards Lifesciences Projects 2025 Constant Currency Sales Growth Of 8% - 10% (RTT News)
06:00AM	Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference (Business Wire)
Dec-02-24 05:45AM	Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi and Korsinsky for More Information - EW (PR Newswire)
Nov-25-24 07:49AM	Edwards Lifesciences announces positive results in one year TAVI trial (Clinical Trials Arena)
03:30AM	Edwards' SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data (Business Wire)
Nov-15-24 05:45AM	Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW (PR Newswire)
Nov-13-24 12:49PM	Shareholders of Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights EW (GlobeNewswire)
10:28AM	US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024 (Medical Device Network)
Nov-12-24 05:45AM	Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW (PR Newswire)
Nov-09-24 12:19AM	Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insight (GuruFocus.com)
11:13AM	Loading…
Nov-02-24 11:13AM	Kessler Topaz Meltzer & Check, LLP Encourages Edwards Lifesciences Corporation Investors with Losses to Contact the Firm (Newsfile)
Nov-01-24 08:55AM	Edwards Lifesciences Corporation (EW) Fell Due to Missed Earnings Expectations and Weak Guidance (Insider Monkey)
Oct-31-24 07:00AM	Edwards, Medtronic and Inari share trial data at TCT conference (MedTech Dive)
Oct-30-24 04:05PM	Data Presented at TCT Reinforce Edwards Lifesciences Commitment to Structural Heart Innovation (Business Wire)
11:00AM	TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation (Business Wire)
Oct-29-24 04:13PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
12:05PM	JPMorgan views Edwards Lifesciences TAVR data positively (TipRanks)
05:45AM	Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW (PR Newswire)
Oct-28-24 03:04PM	Bernstein Lifts Edwards Lifesciences Rating, Sees Balanced Risk-Reward in Tavr Market (GuruFocus.com)
11:00AM	Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients (Business Wire)
09:15AM	International Markets and Edwards Lifesciences (EW): A Deep Dive for Investors (Zacks)
Oct-27-24 12:05PM	Edwards Lifesciences price target raised to $85 from $80 at Barclays (TipRanks)
Oct-25-24 04:23PM	Edwards Skids On Weak Expectations For Its Bread-And-Butter Moneymaker (Investor's Business Daily)
03:01PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research)
07:00AM	Edwards Lifesciences Corp (EW) Q3 2024 Earnings Call Highlights: Strong Growth in TMTT Sales ... (GuruFocus.com)
06:00PM	Loading…
Oct-24-24 06:00PM	Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics (Zacks)
05:11PM	Edwards Reverses Course, Falling On A Mixed Third-Quarter Report (Investor's Business Daily)
04:43PM	Edwards Lifesciences: Q3 Earnings Snapshot (Associated Press Finance)
04:37PM	Edwards Lifesciences Pops After Wrapping A Key Divestiture And Beating Profit Views (Investor's Business Daily)
04:21PM	Edwards Lifesciences Reports Third Quarter Results (Business Wire)
08:24AM	Heres Why Edwards Lifesciences Corporation (EW) Detracted (Insider Monkey)
Oct-22-24 01:13AM	Boston Scientific, Edwards and Dexcom usher in second week of earnings (MedTech Dive)
Oct-21-24 09:16AM	Edwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Oct-17-24 07:05AM	Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024 (Business Wire)
Oct-16-24 10:12AM	Artisan Mid Cap Fund Sold Edwards Lifesciences Corporation (EW) as it Failed to Meet Growth Expectations (Insider Monkey)
10:01AM	Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-08-24 05:39PM	Edwards Lifesciences Soars on TTVR Approval, But Challenges Remain (GuruFocus.com) +6.20%
05:07PM	S&P 500 Gains and Losses Today: Falling Oil Prices Pressure Refining Stocks (Investopedia)
08:06AM	CMS begins national coverage review for tricuspid repair (MedTech Dive)
07:59AM	Edwards Lifesciences price target lowered to $66 from $77 at Canaccord (TipRanks)
Oct-04-24 05:04PM	Vanguard Group Inc's Strategic Acquisition of Edwards Lifesciences Corp Shares (GuruFocus.com)
Sep-28-24 05:09PM	ONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM (PR Newswire)
Sep-17-24 05:07PM	S&P 500 Gains and Losses Today: New Home Battery, Software Lift Enphase Stock (Investopedia)
Sep-05-24 05:30AM	Edwards cuts more than 500 employees after critical care sale (MedTech Dive)
Sep-04-24 11:28AM	Edwards Lifesciences Completes $4.2B Sale of Critical Care to BD (Design & Development Today)
Sep-03-24 04:30PM	Edwards Lifesciences Completes Sale of Critical Care (Business Wire)
Sep-02-24 04:12AM	Edwards Lifesciences reports positive TAVI trial results (Medical Device Network)
Aug-31-24 06:58PM	CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves (Business Wire)
12:35PM	First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves (Business Wire)
Aug-23-24 11:30AM	Edwards Lifesciences (EW) Up 19.4% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-21-24 07:00AM	Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference (Business Wire)
Aug-20-24 06:53AM	Edwards Lifesciences buys JC Medical from Genesis Medtech (Medical Device Network)
06:53AM	Edwards Lifesciences acquires JC Medical from Genesis Medtech (Medical Device Network)
Aug-19-24 07:25AM	Edwards continues M&A spree with Genesis TAVR tech (MedTech Dive)
Aug-16-24 07:27AM	Should You Hold Edward Lifesciences (EW) in Your Portfolio Now? (Zacks)
Aug-13-24 06:01PM	David Rolfe's Strategic Moves in Edwards Lifesciences Corp Highlight Q2 2024 Investments (GuruFocus.com)
Jul-29-24 09:15AM	Edwards Lifesciences (EW) Reliance on International Sales: What Investors Need to Know (Zacks)
Jul-26-24 03:24AM	Heard on the Street Thursday Recap: Detroit Blues (The Wall Street Journal)
Jul-25-24 07:05PM	Analyst Report: Edwards Lifesciences Corporation (Morningstar Research) -31.34%
05:30PM	Heard on the Street Recap: Detroit Blues (The Wall Street Journal)
05:05PM	S&P 500 Gains and Losses Today: Edwards Lifesciences Sinks on Outlook for Key Product (Investopedia)
04:23PM	Edwards Lifesciences Stock Plummeted Today. Here's Why (Investopedia)
04:10PM	Edwards Crashes 31% After Slashing Guidance For Its Biggest Moneymaker (Investor's Business Daily)
12:34PM	Edwards Lifesciences Stock Plunges 28% After Earnings. What Wall Street Thinks. (Barrons.com)
12:30PM	S&P 500s Biggest Loser Has a Heart Valve Problem (The Wall Street Journal)
12:01PM	Top Stock Movers Now: Molina Healthcare, Ford, Honeywell, and More (Investopedia)
11:48AM	Stocks to Watch Thursday: Ford, RTX, Warner Bros, Honeywell (The Wall Street Journal)
09:59AM	Lululemon downgraded, Birkenstock upgraded: Wall Street's top analyst calls (The Fly)
09:02AM	Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash (Zacks)
08:36AM	Why Is Edwards Lifesciences (EW) Stock Down 22% Today? (InvestorPlace)
04:52AM	Edwards Lifesciences to acquire JenaValve and Endotronix (Medical Device Network)
Jul-24-24 06:00PM	Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	Edwards Lifesciences (EW) Q2 Earnings Match Estimates (Zacks)
05:05PM	Edwards Plummets After Slashing Guidance For Its Biggest Moneymaker (Investor's Business Daily)
04:34PM	Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year (Investor's Business Daily)
04:24PM	Edwards Lifesciences: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Edwards Lifesciences Reports Second Quarter Results (Business Wire)
04:15PM	Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix (Business Wire)
Jul-22-24 09:14AM	Edwards Lifesciences expands transcatheter valve replacement sector with Innovalve deal (Medical Device Network)
Jul-20-24 08:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Jul-18-24 11:49AM	Edwards Lifesciences (EW) Buys Innovalve to Boost TMVR Solutions (Zacks)
Jul-17-24 10:00AM	Edwards Lifesciences (EW) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
07:05AM	Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024 (Business Wire)
Jul-16-24 06:53AM	Edwards Lifesciences buys mitral valve business Innovalve in $300m deal (Medical Device Network)
Jul-15-24 11:02AM	Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings? (Zacks)
09:00AM	Edwards Lifesciences to Acquire Innovalve (Business Wire)
07:14AM	Edwards to acquire Innovalve, stake in Affluent Medical (MedTech Dive)
06:33AM	Affluent Medical signs deals with Edwards for structural heart products (Medical Device Network)
Jul-10-24 02:21PM	Final Trades: Edwards Lifesciences, First Citizens, UnitedHealth and iShares US Real Estate ETF (CNBC TV)
Jun-28-24 07:58AM	Is Edwards Lifesciences Corp (NYSE:EW) the Best Medical Stock to Buy in 2024? (Insider Monkey)
Jun-27-24 05:06AM	10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America (Insider Monkey)
Jun-26-24 02:12PM	Final Trades: Edwards Lifesciences, American Tower (CNBC TV)
Jun-20-24 05:48AM	Does Edwards Lifesciences Corporation (EW) Have Attractive Growth Opportunities? (Insider Monkey)
Jun-06-24 07:43AM	Sapien valve performs equally well for small and large aortic annuli, Edwards finds (MedTech Dive)
Jun-05-24 11:45AM	Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR (Business Wire)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '24	Option Exercise	45.28	11,250	509,363	41,811	Dec 09 04:58 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 09 '24	Sale	71.68	11,250	806,406	30,561	Dec 09 04:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 09 '24	Option Exercise	45.28	5,000	226,384	51,936	Dec 09 04:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Dec 09 '24	Sale	71.75	5,000	358,750	46,936	Dec 09 04:58 PM
Ullem Scott B.	Officer	Dec 09 '24	Proposed Sale	71.68	33,750	2,419,214		Dec 09 04:03 PM
Chopra Daveen	CVP, TMTT	Dec 06 '24	Sale	73.27	1,750	128,223	27,583	Dec 06 04:56 PM
Markowitz Wayne	GM & SVP, Surgical	Dec 06 '24	Sale	73.27	583	42,716	9,494	Dec 06 04:56 PM
Markowitz Wayne	Officer	Dec 06 '24	Proposed Sale	73.27	583	42,716		Dec 06 04:14 PM
Chopra Daveen	Officer	Dec 06 '24	Proposed Sale	73.27	1,750	128,222		Dec 06 04:12 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '24	Option Exercise	45.28	5,000	226,384	51,936	Nov 13 06:16 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Nov 13 '24	Sale	65.57	5,000	327,843	46,936	Nov 13 06:16 PM
BOBO DONALD E JR	Officer	Nov 13 '24	Proposed Sale	65.57	15,000	983,529		Nov 13 04:25 PM
Wood Larry L	Global President TAVR & Surg	Nov 05 '24	Sale	65.91	25,000	1,647,862	198,526	Nov 05 05:07 PM
Wood Larry L	Officer	Nov 05 '24	Proposed Sale	65.91	25,000	1,647,862		Nov 05 04:11 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 15 '24	Option Exercise	45.28	5,000	226,384	51,936	Oct 15 05:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Oct 15 '24	Sale	69.51	5,000	347,534	46,936	Oct 15 05:03 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 11 '24	Option Exercise	45.28	5,000	226,384	51,936	Sep 11 06:06 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Sep 11 '24	Sale	66.77	5,000	333,826	46,936	Sep 11 06:06 PM
Chopra Daveen	CVP, TMTT	Aug 20 '24	Sale	69.95	1,250	87,438	29,333	Aug 20 07:42 PM
Chopra Daveen	Officer	Aug 20 '24	Proposed Sale	69.95	1,250	87,438		Aug 20 05:12 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '24	Option Exercise	45.28	5,000	226,384	51,936	Aug 14 05:58 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Aug 14 '24	Sale	66.08	5,000	330,420	46,936	Aug 14 05:58 PM
BOBO DONALD E JR	Officer	Aug 14 '24	Proposed Sale	66.08	15,000	991,260		Aug 14 04:19 PM
Lippis Daniel J.	CVP, JAPAC	Jul 11 '24	Option Exercise	45.28	500	22,638	23,689	Jul 11 05:38 PM
Lippis Daniel J.	CVP, JAPAC	Jul 11 '24	Sale	94.18	500	47,090	23,189	Jul 11 05:38 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jul 10 '24	Option Exercise	45.28	5,000	226,384	51,936	Jul 10 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jul 10 '24	Sale	93.29	5,000	466,474	46,936	Jul 10 05:36 PM
Lippis Daniel J.	CVP, JAPAC	Jun 20 '24	Option Exercise	45.28	535	24,223	24,048	Jun 20 05:44 PM
Lippis Daniel J.	CVP, JAPAC	Jun 20 '24	Sale	90.00	535	48,150	23,513	Jun 20 05:44 PM
Ullem Scott B.	CVP, Chief Financial Officer	Jun 20 '24	Option Exercise	45.28	5,625	254,681	36,186	Jun 20 05:43 PM
Ullem Scott B.	CVP, Chief Financial Officer	Jun 20 '24	Sale	87.51	5,625	492,258	30,561	Jun 20 05:43 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 12 '24	Option Exercise	45.28	5,000	226,384	51,936	Jun 12 05:19 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jun 12 '24	Sale	87.54	5,000	437,696	46,936	Jun 12 05:19 PM
Zovighian Bernard J	CEO	May 30 '24	Sale	87.68	8,617	755,539	68,218	May 30 05:10 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 21 '24	Option Exercise	45.28	5,625	254,681	36,186	May 21 05:09 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 21 '24	Sale	90.45	5,625	508,803	30,561	May 21 05:09 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 10 '24	Option Exercise	45.28	5,000	226,384	52,750	May 13 05:45 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 10 '24	Sale	87.81	5,000	439,038	47,750	May 13 05:45 PM
Lippis Daniel J.	CVP, JAPAC	May 07 '24	Option Exercise	36.75	857	31,495	25,333	May 09 07:40 PM
Lippis Daniel J.	CVP, JAPAC	May 07 '24	Sale	85.60	857	73,359	23,890	May 09 07:40 PM
Zovighian Bernard J	CEO	May 04 '24	Option Exercise	0.00	6,265	0	50,554	May 07 05:53 PM
Zovighian Bernard J	CEO	May 06 '24	Buy	85.74	580	49,753	3,268	May 07 05:53 PM
Ullem Scott B.	CVP, Chief Financial Officer	May 04 '24	Option Exercise	0.00	7,465	0	25,905	May 06 07:18 PM
Szyman Catherine M.	CVP, Critical Care	May 04 '24	Option Exercise	0.00	5,796	0	49,018	May 06 07:18 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 04 '24	Option Exercise	0.00	4,157	0	177,969	May 06 07:18 PM
Wood Larry L	Global President TAVR & Surg	May 04 '24	Option Exercise	0.00	6,675	0	220,022	May 06 07:17 PM
Chopra Daveen	CVP, TMTT	May 04 '24	Option Exercise	0.00	4,713	0	27,172	May 06 07:17 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	May 04 '24	Option Exercise	0.00	5,855	0	45,144	May 06 07:16 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Option Exercise	36.75	29,350	1,078,612	33,836	May 02 06:05 PM
MUSSALLEM MICHAEL A	Director	May 02 '24	Sale	84.77	29,350	2,487,966	4,486	May 02 06:05 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Option Exercise	36.75	14,400	529,200	188,249	May 01 05:17 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	May 01 '24	Sale	84.21	14,400	1,212,687	173,849	May 01 05:17 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Option Exercise	36.75	7,250	266,438	26,324	Apr 30 04:56 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 30 '24	Sale	85.80	7,250	622,062	19,074	Apr 30 04:56 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Option Exercise	36.75	857	31,495	18,345	Apr 09 05:33 PM
Lippis Daniel J.	CVP, JAPAC	Apr 09 '24	Sale	92.34	857	79,135	17,488	Apr 09 05:33 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Option Exercise	36.75	14,400	529,200	188,249	Apr 08 05:10 PM
Lemercier Jean-Luc M	CVP, EMEACLA	Apr 08 '24	Sale	92.32	14,400	1,329,472	173,849	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Option Exercise	36.75	12,500	459,375	52,268	Apr 08 05:10 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Apr 08 '24	Sale	92.33	12,500	1,154,142	39,768	Apr 08 05:10 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Apr 04 06:26 PM
MUSSALLEM MICHAEL A	Director	Apr 04 '24	Sale	92.42	29,350	2,712,418	4,486	Apr 04 06:26 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Option Exercise	36.75	7,255	266,621	26,329	Apr 01 06:55 PM
Ullem Scott B.	CVP, Chief Financial Officer	Apr 01 '24	Sale	94.89	7,255	688,423	19,074	Apr 01 06:55 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Option Exercise	36.75	14,500	532,875	54,003	Mar 13 05:44 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Mar 13 '24	Sale	91.01	14,500	1,319,696	39,503	Mar 13 05:44 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Option Exercise	36.75	14,400	529,200	187,984	Mar 11 06:00 PM
Lemercier Jean-Luc M	CVP, EMEACLA and JAPAC	Mar 11 '24	Sale	91.68	14,400	1,320,149	173,584	Mar 11 06:00 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Option Exercise	36.75	1,715	63,026	18,928	Mar 07 06:22 PM
Lippis Daniel J.	CVP, JAPAC	Mar 07 '24	Sale	90.98	1,715	156,031	17,213	Mar 07 06:22 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Mar 04 07:16 PM
MUSSALLEM MICHAEL A	Director	Mar 04 '24	Sale	86.67	29,350	2,543,737	4,486	Mar 04 07:16 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Option Exercise	36.75	7,255	266,621	26,329	Feb 29 05:12 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 29 '24	Sale	85.59	7,255	620,923	19,074	Feb 29 05:12 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Option Exercise	36.86	7,056	260,107	10,757	Feb 26 05:52 PM
GALLAHUE KIERAN	Director	Feb 23 '24	Sale	87.61	3,058	267,911	67,219	Feb 26 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Option Exercise	59.26	7,000	414,797	30,950	Feb 21 05:52 PM
Chopra Daveen	CVP, TMTT	Feb 21 '24	Sale	86.74	8,200	711,272	22,750	Feb 21 05:52 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Option Exercise	36.75	27,000	992,250	61,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Option Exercise	36.75	20,000	735,000	54,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 15 '24	Sale	85.62	27,000	2,311,654	34,814	Feb 15 05:25 PM
Szyman Catherine M.	CVP, Critical Care	Feb 13 '24	Sale	86.46	20,000	1,729,200	34,814	Feb 15 05:25 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Option Exercise	36.75	11,000	404,250	50,503	Feb 13 04:51 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Feb 13 '24	Sale	85.83	11,000	944,155	39,503	Feb 13 04:51 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Option Exercise	36.75	12,210	448,718	25,297	Feb 12 05:44 PM
SELLERS ROBERT W.A.	SVP, Corporate Controller	Feb 12 '24	Sale	87.00	12,210	1,062,270	13,087	Feb 12 05:44 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Option Exercise	36.86	7,056	260,107	34,036	Feb 08 06:08 PM
STONE HEISZ LESLIE	Director	Feb 08 '24	Sale	86.45	7,056	609,991	26,980	Feb 08 06:08 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Feb 05 06:37 PM
MUSSALLEM MICHAEL A	Director	Feb 05 '24	Sale	87.49	29,350	2,567,754	4,486	Feb 05 06:37 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Option Exercise	36.75	7,255	266,621	26,503	Feb 01 05:52 PM
Ullem Scott B.	CVP, Chief Financial Officer	Feb 01 '24	Sale	78.29	7,255	567,994	19,248	Feb 01 05:52 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Option Exercise	36.75	10,000	367,500	49,503	Jan 12 05:36 PM
BOBO DONALD E JR	CVP,Strategy/Corp Development	Jan 12 '24	Sale	75.67	10,000	756,700	39,503	Jan 12 05:36 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Option Exercise	36.75	29,350	1,078,612	33,836	Jan 05 07:19 PM
MUSSALLEM MICHAEL A	Director	Jan 05 '24	Sale	72.98	29,350	2,142,089	4,486	Jan 05 07:19 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Option Exercise	36.75	14,510	533,242	33,758	Dec 29 04:25 PM
Ullem Scott B.	CVP, Chief Financial Officer	Dec 29 '23	Sale	76.55	14,510	1,110,794	19,248	Dec 29 04:25 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Option Exercise	59.26	7,000	414,797	30,950	Dec 15 05:22 PM
Chopra Daveen	CVP, TMTT	Dec 15 '23	Sale	78.25	7,000	547,724	23,950	Dec 15 05:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EW

Edwards Lifesciences Corp

Upgrade your FINVIZ experience